Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0D0OO
|
|||
Former ID |
DNC001744
|
|||
Drug Name |
ISIS 191759
|
|||
Drug Type |
Antisense drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Company |
Isis Pharmaceuticals
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | DGAT1 messenger RNA (DGAT1 mRNA) | Target Info | . | [1] |
BioCyc | Triacylglycerol biosynthesis | |||
KEGG Pathway | Glycerolipid metabolism | |||
Retinol metabolism | ||||
Metabolic pathways | ||||
Fat digestion and absorption | ||||
Pathwhiz Pathway | Retinol Metabolism | |||
Reactome | Acyl chain remodeling of DAG and TAG | |||
Triglyceride Biosynthesis | ||||
WikiPathways | Vitamin A and Carotenoid Metabolism | |||
Statin Pathway | ||||
Triacylglyceride Synthesis | ||||
Glycerophospholipid biosynthesis | ||||
Fatty acid, triacylglycerol, and ketone body metabolism |
References | Top | |||
---|---|---|---|---|
REF 1 | US patent application no. 7,414,033, Modulation of diacylglycerol acyltransferase 1 expression. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.